» Articles » PMID: 6969402

Purification and Some Characteristics of Human T-cell Growth Factor from Phytohemagglutinin-stimulated Lymphocyte-conditioned Media

Overview
Specialty Science
Date 1980 Oct 1
PMID 6969402
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Human T-cell growth factor (TCGF), a mitogenic protein that appears in the media of cultured lymphocytes after phytohemagglutinin-stimulation, has been purified more than 400-fold from serum-free conditioned media by using a sequence of ion exchange chromatography and gel filtration. The purified growth factor elutes as a broad peak from DEAE-Sepharose, focuses diffusely at a pH of about 6.8 on isoelectric focusing (suggesting heterogeneity in electrical charge), has an estimated molecular weight of approximately 23,000 as judged by gel filtration (12,000-13,000 on Na-DodSO4/polyacrylamide gel electrophoresis), is resistant to DNase and RNase, is degraded by trypsin, and does not adhere to any of several lectin-Sepharoses. These characteristics indicate that it is nonglycosylated and protein in nature. The activity of the factor determined by cell counts or [3H]thymidine incorporation in human T lymphoblasts, is stable at room temperature in crude conditioned media, but the partially purified factor requires the addition of albumin or polyethylene glycol to maintain stability. Unlike the crude conditioned media, the purified factor lacks colony-stimulating activity and, unlike lectins, antigens, and crude conditioned media, it does not initiate blastogenesis in peripheral blood lymphocytes but is a selective mitogen for T cells that have undergone blast transformation secondary to exposure to a lectin or antigen. This indicates that the factor is a second signal in the T-cell immune response. The partially purified factor has been used to selectively grow several human T-cell lines, including cells that are cytotoxic to a variety of target cells.

Citing Articles

Functional Interactions Between Recombinant Serum Amyloid A1 (SAA1) and Chemokines in Leukocyte Recruitment.

Van Damme J, Struyf S, Proost P, Opdenakker G, Gouwy M Int J Mol Sci. 2025; 26(5).

PMID: 40076881 PMC: 11900440. DOI: 10.3390/ijms26052258.


Paradoxical imbalance between activated lymphocyte protein synthesis capacity and rapid division rate.

Seedhom M, Dersh D, Holly J, Pavon-Eternod M, Wei J, Angel M Elife. 2024; 12.

PMID: 38512721 PMC: 10957176. DOI: 10.7554/eLife.89015.


Low-dose interleukin-2 therapy in systemic lupus erythematosus.

La Cava A Rheumatol Immunol Res. 2023; 4(3):150-156.

PMID: 37781677 PMC: 10538619. DOI: 10.2478/rir-2023-0021.


Regulatory T-cell dysfunction and its implication for cell therapy.

Valentini N, Requejo Cier C, Lamarche C Clin Exp Immunol. 2023; 213(1):40-49.

PMID: 37158407 PMC: 10324551. DOI: 10.1093/cei/uxad051.


The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4 T cells resembling iTreg.

Tauber P, Kratzer B, Schatzlmaier P, Smole U, Kohler C, Rausch L Front Immunol. 2023; 14:1094694.

PMID: 37090735 PMC: 10117943. DOI: 10.3389/fimmu.2023.1094694.


References
1.
Andrews P . Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem J. 1964; 91(2):222-33. PMC: 1202876. DOI: 10.1042/bj0910222. View

2.
Chervenick P, BOGGS D . In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals. Blood. 1971; 37(2):131-5. View

3.
Morgan D, Ruscetti F, Gallo R . Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976; 193(4257):1007-8. DOI: 10.1126/science.181845. View

4.
Kasakura S . Cytotoxic lymphocytes induced by soluble factors derived from the medium of leukocyte cultures. J Immunol. 1977; 118(1):43-7. View

5.
Burgess A, Wilson E, Metcalf D . Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood. 1977; 49(4):573-83. View